A new research study has shown that pancreatic cancer cells can be coaxed to revert back toward normal cells by introducing a protein called E47.
E47 binds to specific DNA sequences and controls genes involved in growth and differentiation. The research provides hope for a new treatment approach for the more than 40,000 people who die from the disease each year in the United States.
“For the first time, we have shown that overexpression of a single gene can reduce the tumor-promoting potential of pancreatic adenocarcinoma cells and reprogram them toward their original cell type. Thus, pancreatic cancer cells retain a genetic memory which we hope to exploit,” said Pamela Itkin-Ansari, Ph.D., adjunct professor in the Development, Aging, and Regeneration Program at Sanford-Burnham and lead author of the study published today in the journal Pancreas.
E47 turns the clock back
The study, a collaborative effort between Sanford-Burnham, UC San Diego, where Itkin-Ansari holds a joint appointment, and Purdue University, generated human pancreatic ductal adenocarcinoma cell lines to make higher-than-normal levels of E47. The increased amount of E47 caused cells to stall in the G0/G1 growth phase, and differentiate back toward an acinar cell phenotype.
In-vivo studies showed that when the reprogrammed cancer cells were introduced into mice, their ability to form tumors was greatly diminished compared to untreated adenocarcinoma cells.
“Presently, pancreatic adenocarcinoma is treated with cytotoxic agents, yet the average survival for patients post-diagnosis is merely six months, and the improvements in therapies are measured in days,” said Andrew M. Lowy, M.D., professor of surgery at the UC San Diego Moores Cancer Center and co-chair of the National Cancer Institute’s Pancreatic Cancer Task Force. “The finding that we can differentiate these cancer cells back to a non-threatening phenotype is encouraging. Indeed, there is a precedent for cell differentiation therapy in that the approach has been used to treat acute promyelocytic leukemia (APL) and some neuroblastomas successfully.”
“Our next step is to test primary patient-derived tumor tissue to determine whether E47 can produce similar results, potentially providing a novel therapeutic approach to combating this highly lethal disease,” said Itkin-Ansari. “Additionally, we are screening for molecules—potential drugs—that can induce overexpression of E47.”
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Advances in Pancreatic Cancer — and Symptoms to Knowon December 4, 2020 at 2:16 pm
Pancreatic cancer survival rates have improved considerably over the past two decades. Here's what to know about warning signs and new treatments.
- AB Science: AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer withon December 4, 2020 at 10:35 am
AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer with pain was successful and reached it ...
- Pancreatic Cancer - Epidemiology Forecast to 2029on December 4, 2020 at 2:38 am
Reportlinker.com announces the release of the report "Pancreatic Cancer - Epidemiology Forecast to 2029" - Pancreatic cancer occurs when cells in the pancreas develop mutations in their DNA and grow ...
- AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer with pain was successfulon December 4, 2020 at 1:51 am
AB Science announces that confirmatory Phase 3 study AB12005 with masitinibin first line pancreatic cancer with pain was successful and ...
- 'Magic' Morristown Man, Known By Many, Faces Pancreatic Canceron December 3, 2020 at 8:26 am
Hogie seemingly knows everyone in North Jersey, friends say. Here's how to help as he battles the disease that took his mother.
- Pancreatic cancer survivor wants to raise more awareness for the diseaseon December 1, 2020 at 2:39 pm
"The months of not knowing were stressful. They were stressful on me; they were on my family," said Matt Wilson, who was diagnosed with the disease.
- ‘Girlfriends’ Star Keesha Sharp on Losing Her Mother to Pancreatic Canceron December 1, 2020 at 12:36 pm
Four summers ago, Keesha Sharp found out that her mother had been diagnosed with pancreatic cancer — the third leading cause of cancer-related deaths in America. Sadly, her mom died in ...
- Curiosity and Creativity Fuel Advancements in Pancreatic Cancer Researchon November 30, 2020 at 10:54 pm
From cancer to COVID to computer technology, innovation often begins as a spark of creativity lit by a researcher’s curiosity. Whether viewing existing research through a different lens or bringing a ...
- World Pancreatic Cancer Dayon November 25, 2020 at 3:53 pm
ROCKFORD, Ill. (WIFR) - As World Pancreatic Cancer Day falls during a time and with the coronavirus pandemic changing the way many of us go to the doctor, early detection could be delayed. With the ...
- Pancreatic cancer month - join the fight | Houghtaling and Downeyon November 24, 2020 at 3:46 am
By supporting research, staying vigilant about our own health and risk factors, and making our families and friends aware of this deadly disease, we will help drive the search for hope and a cure." ...
via Bing News